Value Bridge — DENVER HEALTH MEDICAL CENTER
Current $-90M → Target $-65M (+$24.6M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-90.0M
Current EBITDA
$-65.5M
Target EBITDA
+$24.6M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$5.6M
Payer Mix Optimization
$13.3M
Cost to Collect Reduction
$4.4M
Clean Claim Improvement
$3.3M
Volume & Rate Growth
$22.2M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-90M to $-65M. The highest-impact lever is Volume & Rate Growth at $8.9M probability-weighted.
IC talking point: "We see $25M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $270M in equity value creation."